Market closed
CVRx/$CVRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Ticker
$CVRX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
206
Website
CVRx Metrics
BasicAdvanced
$305M
-
-$2.65
1.25
-
Price and volume
Market cap
$305M
Beta
1.25
52-week high
$19.24
52-week low
$6.40
Average daily volume
219K
Financial strength
Current ratio
12.062
Quick ratio
10.704
Long term debt to equity
70.579
Total debt to equity
70.976
Interest coverage (TTM)
-13.53%
Management effectiveness
Return on assets (TTM)
-29.91%
Return on equity (TTM)
-81.58%
Valuation
Price to revenue (TTM)
5.163
Price to book
4.18
Price to tangible book (TTM)
4.18
Price to free cash flow (TTM)
-6.538
Growth
Revenue change (TTM)
30.53%
Earnings per share change (TTM)
33.69%
3-year revenue growth (CAGR)
57.87%
3-year earnings per share growth (CAGR)
-13.90%
What the Analysts think about CVRx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for CVRx stock.
CVRx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
CVRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
CVRx News
AllArticlesVideos
CVRx Reports Preliminary First Quarter 2025 Financial Results
GlobeNewsWire·13 hours ago
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
GlobeNewsWire·2 months ago
CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CVRx stock?
CVRx (CVRX) has a market cap of $305M as of April 08, 2025.
What is the P/E ratio for CVRx stock?
The price to earnings (P/E) ratio for CVRx (CVRX) stock is 0 as of April 08, 2025.
Does CVRx stock pay dividends?
No, CVRx (CVRX) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next CVRx dividend payment date?
CVRx (CVRX) stock does not pay dividends to its shareholders.
What is the beta indicator for CVRx?
CVRx (CVRX) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.